ClinicalTrials.govpublic full text
A Phase 2, Safety, Tolerability, and Efficacy Study of PD 0360324 in Chronic Pulmonary Sarcoidosis
pulmonary sarcoidosis, phase 2, randomized, double blind, placebo controlled, parallel, 20 week safety, tolerability, and efficacy study, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 846850
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.